MODERN APPROACHES TO TREATMENT OF COMORBID PATHOLOGY BRONCHOPULMONARY AND THE CARDIOVASCULAR SYSTEM

Authors:

Abstract:

Chronic obstructive pulmonary disease is a weighty social health and economic importance, and remains one of the major causes of morbidity and mortality worldwide. Presently, special attention is paid to comorbid conditions, when the patient has a combination of pathology respiratory and cardiovascular systems. This research has been devoted to finding ways to optimize the treatment of moderate acute exacerbations of chronic obstructive pulmonary disease with the complication of bronchoectasis on the background of arterial hypertension.

Keywords:

obstructive bronchitis bronchiectasis arterial hypertension glutoksim L-arginine

References:

1. Buch P. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study / P. Buch, J. Friberg, H. Scharling [et al.] // Eur. - 2003, Vol. 21 (6), P. 1012-1016.
2. Dvoretskiy L. I. Infection and chronic obstructive pulmonary disease / L. I. Dvoretskiy // Consilium Medicum. - 2001. - №3 (12). - P. 587-595.
3. Dankner R. Predictors of cardiac and noncardiac mortality among 14,697 patients with coronary heart disease / R. Dankner, U. Goldbourt, V. Boyko [et al.] // Am. J. Cardiol., - 2003, Vol. 91 (2), P. 121-127.
4. Dzyublik A. Y. Exacerbation of chronic obstructive pulmonary disease: state of the problem / A. Y. Dzyublik, T. A. Pertseva // Ukr. pulmonol Journal. - 2009. - №2. – 10 p.
5. Dyachenko V. V. Place of oral cephalosporins of the III generation in treatment of respiratory system infection // Terapia. Ukranian medical News. - 2010. - №10. - P. 40-42.
6. Feshenko Y. I. Control of chronic obstructive pulmonary disease – whether it is possible today? / Y. I. Feshenko // Health Protection of Ukraine. - Topical number. - 2011. - №1. - P. 1-3.
7. Feshenko Y. I. The new edition of the Global Initiative to guide Obstructive Pulmonary Disease (GOLD) / Y. I. Feshenko // Health Protection of Ukraine. - Topical number. - 2012. - №2 (18). - P. 10-11.
8. Feshenko Y. I. Obstructive pulmonary disease / Y. I. Feshenko, L. A. Yashina, A. M. Polyanskaya [et al.] // - Singapore: - 2004. - 287 p.
9. Gembitskaya T. E. Clinical features, diagnosis and treatment of certain genetically caused diseases of the respiratory system in adults: Thesis of Doctor. med. sciences: 14.00.43 / Proc. Institute of Pulmonology. - Leningrad, - 1987. - 158 p.
10. Global initiative for chronic obstructive lung gisease. WHO, updated 2011.
11. Іlnitsky R. І. Pecularities of іmunologіcal reactivity in patients with chronic obstructive pulmonary disease / R. І. Іlnitsky // Ukr. pulmonol. J. - 2007. - №2 (56). - P. 21-25.
12. Perederiy V. G. Immune status, the principles of evaluation and correction of immune disorders / V. G. Perederiy, A. M. Zemskov, N. G. Bychkov [et al.] // - K.: Health Protection, - 1995. – 211 p.
13. Rabe K. F. Roflumilast for the treatment of chronic obstructive pulmonary disease / K. F. Rabe // Expert Rev Resp Med. - 2010. - Vol. 4. - P. 543-555.
14. Soodaeva S. K. Oxidant and antioxidant system in chronic obstructive pulmonary disease / S. K. Soodaeva // Chronic obstructive pulmonary disease. - SPb.: Nevsky dіalekt, - 1998. - P. 92-111.
15. Tager M. Evidense of a defective thiol status of alveolar macrophages from COPD patients and smokers. COPD / M. Tager, A. Biecyk, T. Kohnelin [et al.] // Free Radic. Biol. Med. - 2000. - Vol. 29, №11. - P. 1160-1165.

Publication:

«World of Medicine and Biology» Vol. 13 No. 59 (2017) , с. 64-68
УДК 616.23/24:616.2]-031-085